NO20035200L - Flytende farmasöytisk blanding - Google Patents

Flytende farmasöytisk blanding

Info

Publication number: NO20035200L
Authority: NO; Norway
Prior art keywords: liquid pharmaceutical; pharmaceutical mixture; mixture; liquid; pharmaceutical
Prior art date: 2001-05-25

Application number

NO20035200A

Other languages

English (en)

Other versions

NO20035200D0 (no

Inventor

Neema Mahesh Kulkarni

Michael Schneider

Steven Bernard Silbering

Hans Richard Meyer-Wonnay

Nahid Sanii-Yahyai

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-25

Filing date

2003-11-24

Publication date

2003-11-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26968180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20035200(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-11-24 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2003-11-24 Publication of NO20035200L publication Critical patent/NO20035200L/no

2003-11-24 Publication of NO20035200D0 publication Critical patent/NO20035200D0/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Anesthesiology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Pyrrole Compounds (AREA)

NO20035200A 2001-05-25 2003-11-24 Flytende farmasöytisk blanding NO20035200D0 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US29383201P	2001-05-25	2001-05-25
US34373301P	2001-10-25	2001-10-25
PCT/IB2002/001500 WO2002094220A1 (en)	2001-05-25	2002-04-29	Liquid pharmaceutical composition

Publications (2)

Publication Number	Publication Date
NO20035200L true NO20035200L (no)	2003-11-24
NO20035200D0 NO20035200D0 (no)	2003-11-24

Family

ID=26968180

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20035200A NO20035200D0 (no)	2001-05-25	2003-11-24	Flytende farmasöytisk blanding

Country Status (43)

Country	Link
US (2)	US20020198261A1 (no)
EP (1)	EP1395242B1 (no)
JP (1)	JP2004534764A (no)
KR (1)	KR100582963B1 (no)
CN (1)	CN100346779C (no)
AP (1)	AP1815A (no)
AR (1)	AR033922A1 (no)
AT (1)	ATE334656T1 (no)
AU (1)	AU2002258026B2 (no)
BG (1)	BG108376A (no)
BR (1)	BR0209973A (no)
CA (1)	CA2446574C (no)
CR (1)	CR7150A (no)
CY (1)	CY1105147T1 (no)
CZ (1)	CZ299755B6 (no)
DE (1)	DE60213592T2 (no)
DK (1)	DK1395242T3 (no)
DO (1)	DOP2002000403A (no)
EA (1)	EA008087B1 (no)
EE (1)	EE200300587A (no)
EG (1)	EG24078A (no)
ES (1)	ES2265040T3 (no)
GE (1)	GEP20053620B (no)
HR (1)	HRP20030833B1 (no)
HU (1)	HUP0401366A2 (no)
IL (1)	IL158359A0 (no)
IS (1)	IS2428B (no)
MA (1)	MA27026A1 (no)
MX (1)	MXPA03009392A (no)
MY (1)	MY128615A (no)
NO (1)	NO20035200D0 (no)
NZ (1)	NZ529173A (no)
OA (1)	OA12604A (no)
PA (1)	PA8545901A1 (no)
PE (1)	PE20030087A1 (no)
PL (1)	PL366384A1 (no)
PT (1)	PT1395242E (no)
RS (1)	RS87203A (no)
SI (1)	SI1395242T1 (no)
SK (1)	SK286227B6 (no)
SV (1)	SV2003001053A (no)
WO (1)	WO2002094220A1 (no)
ZA (1)	ZA200308393B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0934061B3 (en)	1996-07-24	2015-01-21	Warner-Lambert Company LLC	Isobutylgaba and its derivatives for the treatment of pain
US8048917B2 (en)	2005-04-06	2011-11-01	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
JP2005539092A (ja) *	2002-08-15	2005-12-22	ファイザー・インク	縮合二環式または三環式アミノ酸の治療における使用
CA2451267A1 (en) *	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
WO2004054566A1 (en) *	2002-12-13	2004-07-01	Warner-Lambert Company Llc	Pregabalin derivatives for the treatment of fibromyalgia and other disorders
EP1480631B1 (en) *	2002-12-20	2007-08-01	Dynogen Pharmaceuticals Inc.	Methods of treating non-painful bladder disorders using alpha2-delta- subunit calcium channel modulators
US7169812B2 (en) *	2003-07-01	2007-01-30	Medtronic, Inc.	Process for producing injectable gabapentin compositions
ATE449633T1 (de) *	2003-09-12	2009-12-15	Pfizer	Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
ATE526988T1 (de) *	2003-10-08	2011-10-15	Mallinckrodt Llc	Methylphenidat-lösung und relevante verabreichungs- und herstellungsverfahren
US20050090548A1 (en) *	2003-10-23	2005-04-28	Medtronic, Inc.	Intrathecal gabapentin for treatment of epilepsy
US20050090549A1 (en) *	2003-10-23	2005-04-28	Medtronic, Inc.	Intrathecal gabapentin for treatment of pain
EP1543831A1 (en) *	2003-12-18	2005-06-22	Pfizer GmbH Arzneimittelwerk Gödecke	Pregabalin composition
DE102004015752B4 (de) *	2004-03-31	2007-04-05	Christian-Albrechts-Universität Zu Kiel	Verwendung von Gabapentin-Laktam zur Behandlung renaler Erkrankungen
KR100870381B1 (ko) *	2004-10-14	2008-11-25	다이킨 고교 가부시키가이샤	분위기개변방법, 그리고 이에 이용되는 분무제 및 분무장치
WO2007017510A2 (de) *	2005-08-11	2007-02-15	Boehringer Ingelheim International Gmbh	Isophthalsäurediamide zur behandlung der alzheimer erkrankung
EP1919861A2 (de) *	2005-08-11	2008-05-14	Boehringer Ingelheim International GmbH	Verbindungen zur behandlung der alzheimer erkrankung
DE102007019071A1 (de) *	2007-04-23	2008-10-30	Ratiopharm Gmbh	Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
SG157299A1 (en) *	2008-05-09	2009-12-29	Agency Science Tech & Res	Diagnosis and treatment of kawasaki disease
EP2246044A1 (en) *	2009-04-21	2010-11-03	Pierre Fabre Dermo-Cosmétique	Paediatric solutions comprising a beta-blocker
HU230031B1 (hu)	2010-03-01	2015-05-28	Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság	Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
TR201005241A1 (tr) *	2010-05-25	2012-01-23	Sanovel �La� San. Ve T�C. A.�.	Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
WO2015144825A1 (en) *	2014-03-27	2015-10-01	Sanovel Ilac Sanayi Ve Ticaret A.S.	Oral liquid pharmaceutical solution of gabapentin
CN104940930A (zh) *	2015-05-31	2015-09-30	黑龙江佰彤儿童药物研究有限公司	一种治疗儿童癫痫药物口服乳剂及其制备方法
US11918684B2 (en)	2017-03-13	2024-03-05	Liqmeds Worldwide Limited	Pharmaceutical composition of oral suspension of immunosuppressive agents
WO2019038584A1 (en)	2017-08-19	2019-02-28	Ftf Pharma Private Limited	An oral pharmaceutical composition comprising zonisamide and process of preparation thereof
WO2019186515A1 (en) *	2018-03-30	2019-10-03	Ftf Pharma Private Limited	Liquid pharmaceutical compositions of antiepileptic drugs
US12083222B2 (en)	2018-08-18	2024-09-10	Oncosol Limited	Chemotherapeutic pharmaceutical suspension for oral dosage
US20210308044A1 (en)	2018-08-18	2021-10-07	Ftf Pharma Private Limited	Pharmaceutical suspension for oral dosage
CN113631150A (zh)	2019-03-26	2021-11-09	奥赖恩公司	普瑞巴林制剂及其用途
HU231397B1 (hu)	2021-01-22	2023-06-28	Egis Gyógyszergyár Zrt.	Pregabalint tartalmazó topikális gyógyszerkészítmény
EP4281059A4 (en)	2021-01-22	2025-01-15	Egis Gyógyszergyár Zrt.	TOPICAL FORMULATION WITH MODIFIED PHOSPHOLIPID COMPOUNDS
US20240099989A1 (en) *	2021-02-05	2024-03-28	Kinki University	Agent for preventing or improving peripheral neuropathy
WO2023034269A1 (en) *	2021-08-31	2023-03-09	Avion Pharmaceuticals, Llc	Stable gabapentin powder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6294520B1 (en) *	1989-03-27	2001-09-25	Albert T. Naito	Material for passage through the blood-brain barrier
KR100602047B1 (ko) *	1998-05-15	2006-07-19	워너-램버트 캄파니 엘엘씨	감마-아미노부티르산 유도체의 안정화된 제약 제제 및그의 제조 방법
HRP20030420A2 (en) *	2000-11-30	2004-08-31	Pfizer Prod Inc	Combination of gaba agonists and sorbitol dehydrogenase inhibitors

2002
- 2002-04-29 GE GE5340A patent/GEP20053620B/en unknown
- 2002-04-29 BR BR0209973-0A patent/BR0209973A/pt not_active IP Right Cessation
- 2002-04-29 CN CNB028098080A patent/CN100346779C/zh not_active Expired - Fee Related
- 2002-04-29 AU AU2002258026A patent/AU2002258026B2/en not_active Ceased
- 2002-04-29 EP EP02727834A patent/EP1395242B1/en not_active Expired - Lifetime
- 2002-04-29 IL IL15835902A patent/IL158359A0/xx unknown
- 2002-04-29 CA CA002446574A patent/CA2446574C/en not_active Expired - Fee Related
- 2002-04-29 EA EA200301152A patent/EA008087B1/ru not_active IP Right Cessation
- 2002-04-29 ES ES02727834T patent/ES2265040T3/es not_active Expired - Lifetime
- 2002-04-29 MX MXPA03009392A patent/MXPA03009392A/es active IP Right Grant
- 2002-04-29 AT AT02727834T patent/ATE334656T1/de not_active IP Right Cessation
- 2002-04-29 WO PCT/IB2002/001500 patent/WO2002094220A1/en not_active Ceased
- 2002-04-29 OA OA1200300296A patent/OA12604A/en unknown
- 2002-04-29 PL PL02366384A patent/PL366384A1/xx not_active Application Discontinuation
- 2002-04-29 SK SK1411-2003A patent/SK286227B6/sk not_active IP Right Cessation
- 2002-04-29 DE DE60213592T patent/DE60213592T2/de not_active Expired - Fee Related
- 2002-04-29 HU HU0401366A patent/HUP0401366A2/hu unknown
- 2002-04-29 EE EEP200300587A patent/EE200300587A/xx unknown
- 2002-04-29 PT PT02727834T patent/PT1395242E/pt unknown
- 2002-04-29 KR KR1020037015326A patent/KR100582963B1/ko not_active Expired - Fee Related
- 2002-04-29 RS YU87203A patent/RS87203A/sr unknown
- 2002-04-29 NZ NZ529173A patent/NZ529173A/en unknown
- 2002-04-29 CZ CZ20033066A patent/CZ299755B6/cs not_active IP Right Cessation
- 2002-04-29 AP APAP/P/2003/002907A patent/AP1815A/en active
- 2002-04-29 HR HR20030833A patent/HRP20030833B1/xx not_active IP Right Cessation
- 2002-04-29 DK DK02727834T patent/DK1395242T3/da active
- 2002-04-29 SI SI200230371T patent/SI1395242T1/xx unknown
- 2002-04-29 JP JP2002590939A patent/JP2004534764A/ja active Pending
- 2002-05-21 MY MYPI20021869A patent/MY128615A/en unknown
- 2002-05-22 EG EG20020541A patent/EG24078A/xx active
- 2002-05-23 PE PE2002000433A patent/PE20030087A1/es not_active Application Discontinuation
- 2002-05-23 AR ARP020101922A patent/AR033922A1/es unknown
- 2002-05-23 DO DO2002000403A patent/DOP2002000403A/es unknown
- 2002-05-24 SV SV2002001053A patent/SV2003001053A/es not_active Application Discontinuation
- 2002-05-24 PA PA20028545901A patent/PA8545901A1/es unknown
- 2002-05-28 US US10/156,213 patent/US20020198261A1/en not_active Abandoned
2003
- 2003-06-24 US US10/602,215 patent/US7256216B2/en not_active Expired - Lifetime
- 2003-10-09 IS IS6986A patent/IS2428B/is unknown
- 2003-10-28 ZA ZA2003/08393A patent/ZA200308393B/en unknown
- 2003-11-17 CR CR7150A patent/CR7150A/es not_active Application Discontinuation
- 2003-11-19 MA MA27406A patent/MA27026A1/fr unknown
- 2003-11-21 BG BG108376A patent/BG108376A/bg unknown
- 2003-11-24 NO NO20035200A patent/NO20035200D0/no not_active Application Discontinuation
2006
- 2006-08-10 CY CY20061101125T patent/CY1105147T1/el unknown

Also Published As

Publication number	Publication date
JP2004534764A (ja)	2004-11-18
AR033922A1 (es)	2004-01-07
US7256216B2 (en)	2007-08-14
BG108376A (bg)	2005-04-30
ZA200308393B (en)	2005-04-26
CZ299755B6 (cs)	2008-11-12
EG24078A (en)	2008-05-11
HRP20030833B1 (en)	2007-04-30
DE60213592D1 (de)	2006-09-14
CR7150A (es)	2004-02-23
OA12604A (en)	2006-06-08
MA27026A1 (fr)	2004-12-20
CN100346779C (zh)	2007-11-07
PE20030087A1 (es)	2003-02-14
AP1815A (en)	2008-01-04
US20020198261A1 (en)	2002-12-26
KR100582963B1 (ko)	2006-05-24
SV2003001053A (es)	2003-03-18
GEP20053620B (en)	2005-09-26
WO2002094220A1 (en)	2002-11-28
DK1395242T3 (da)	2006-10-30
EA200301152A1 (ru)	2004-04-29
PL366384A1 (en)	2005-01-24
MY128615A (en)	2007-02-28
PA8545901A1 (es)	2003-09-05
DE60213592T2 (de)	2007-08-09
RS87203A (sr)	2006-10-27
BR0209973A (pt)	2004-04-06
CN1509165A (zh)	2004-06-30
EA008087B1 (ru)	2007-02-27
IS6986A (is)	2003-10-09
CY1105147T1 (el)	2010-03-03
NZ529173A (en)	2005-07-29
EP1395242B1 (en)	2006-08-02
US20040072904A1 (en)	2004-04-15
MXPA03009392A (es)	2004-01-29
PT1395242E (pt)	2006-11-30
HK1062646A1 (zh)	2004-11-19
DOP2002000403A (es)	2002-11-30
CA2446574C (en)	2008-04-01
CA2446574A1 (en)	2002-11-28
IL158359A0 (en)	2004-05-12
KR20040003006A (ko)	2004-01-07
NO20035200D0 (no)	2003-11-24
AP2003002907A0 (en)	2003-12-31
CZ20033066A3 (cs)	2004-08-18
EE200300587A (et)	2004-02-16
AU2002258026B2 (en)	2007-08-02
SK286227B6 (sk)	2008-05-06
ES2265040T3 (es)	2007-02-01
HRP20030833A2 (en)	2004-08-31
EP1395242A1 (en)	2004-03-10
ATE334656T1 (de)	2006-08-15
SI1395242T1 (en)	2006-10-31
IS2428B (is)	2008-10-15
HUP0401366A2 (hu)	2004-11-29
SK14112003A3 (sk)	2004-08-03

Publication	Publication Date	Title
NO20035200D0 (no)	2003-11-24	Flytende farmasöytisk blanding
NO20033384L (no)	2003-09-25	Farmasoytisk formulering
DK1424893T3 (da)	2006-08-14	Fungicid blanding indeholdende arylamidderivater
DK1370367T3 (da)	2005-10-17	Væskeforstöver
NO20033785D0 (no)	2003-08-26	Farmasöytisk formulering
NO20033556D0 (no)	2003-08-11	Farmasöytiske preparater
FI20011478L (fi)	2003-01-06	Farmaseuttinen koostumus
DE60214961D1 (de)	2006-11-09	Anzeigegerät
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
NO20035315D0 (no)	2003-11-28	Farmasöytiske kombinasjoner
FI20022128A7 (fi)	2003-06-06	Farmaseuttinen koostumus
NO20031246D0 (no)	2003-03-18	Farmasöytisk blanding
NO20042502L (no)	2004-08-09	Farmasoytisk formulering omfattende bicalutamid
NO20041485L (no)	2004-04-13	Farmasoytisk formulering omfattende (R)-bicalutamid
NO20023357D0 (no)	2002-07-11	Blanding
DE50202942D1 (de)	2005-06-02	Basenhältige mikronährstoffmischung
NO20015534D0 (no)	2001-11-12	Farmasöytisk blandeapparat
FI20010970L (fi)	2002-11-10	Nestekoostumus
FI20012242A0 (fi)	2001-11-19	Uudet farmaseuttiset yhdisteet
NO20041236L (no)	2004-03-24	Farmasoytisk formulering
NO20011529D0 (no)	2001-03-26	Væske-adskiller
DE60204167D1 (de)	2005-06-16	Flüssigkeitsspender
SE0103565D0 (sv)	2001-10-25	Pharmaceutical formulation
SE0102957D0 (sv)	2001-09-04	Pharmaceutical formulation
SE0101326D0 (sv)	2001-04-12	Pharmaceutical formulation

Legal Events

Date	Code	Title	Description
2009-11-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application